Cancer is arguably the most well-studied disease in modern medicine – and yet, tackling it still represents an immense challenge for scientists across the world. Continue reading The New Era of Cancer Treatment: ‘Living Drugs’
by Beth Webb Cancer and Cardiovascular Disease Cancer and cardiovascular disease (CVD) are the two-leading causes of death worldwide. However, survival rates for both diseases are higher than ever suggesting that people are more likely to suffer from both cancer and CVD in their lifetime. CVD includes all heart and circulatory diseases such as; coronary heart disease, angina, heart attack, congenital heart disease, hypertension, stroke, … Continue reading The big C: cancer vs cardiovascular disease – the importance of translational medicine
All sporadic cancer is caused by acquired somatic mutations (mutations that take place within cells of the body that are not passed down/inherited). Mutations often occur by incorrect repair of DNA damage by impaired DNA pathways such as the nucleotide excision repair (NER) pathway and the DNA mismatch repair (MMR) pathway. Continue reading Investigating Somatic Mutations in Cancer Development
By Jenni Lacey, Cancer Research UK
At Cancer Research UK, we invest over £350 million each year on high-calibre cancer research which we believe has the potential to provide the greatest benefit to the public and cancer patients. We are always looking for novel ways to spark and fund creative ideas, and encourage fresh thinking. That’s why we’ve developed new ways of supporting research and stimulating innovation. We have funding schemes that are open to researchers from all backgrounds, including biochemists, and those not currently working in cancer research.